Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research report report published on Monday. The firm issued a buy rating on the stock.

Mannatech Price Performance

NASDAQ MTEX opened at $10.90 on Monday. Mannatech has a 12 month low of $6.75 and a 12 month high of $16.49. The stock has a market cap of $20.55 million, a price-to-earnings ratio of -13.46 and a beta of 1.06. The company’s 50 day moving average is $12.18 and its two-hundred day moving average is $9.90. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.